RECBIO-B(02179): Wei Qifang and Wang Jing appointed as executive directors.

Announcement: The proposal to cancel the Board of Supervisors has been approved at the provisional shareholders' meeting of RECBIO-B(02179). Therefore, starting from December 19, 2025, the company will no longer have a Board of Supervisors and the "Rules of Procedure of the Board of Supervisors of Jiangsu Ruikang Biotechnology Co., Ltd." will be abolished. The Audit Committee under the Board of Directors will exercise the supervisory functions granted by company law and regulations. The current members of the Board of Supervisors will no longer serve as supervisors of the company. At the provisional shareholders' meeting, Mr. Xu Haoyu was appointed as a non-executive director; Mr. Wei Qifang was appointed as an executive director; and Ms. Wang Jing was appointed as an executive director.